Skip to main content
SLDB
NASDAQ Life Sciences

Solid Biosciences Q2 Loss Widens to $54.8M, Cash Runway Extended to Mid-2028

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$8.65
Mkt Cap
$857.496M
52W Low
$3.79
52W High
$11.45
52W Position info
128% above low
Off High info
24% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

SLDB has more than doubled off its 52-week low of $3.79 on light trading volume (0.3× avg).

Summary

Solid Biosciences reported a Q2 net loss of $54.8 million, wider than the prior year, driven by increased R&D spending on its gene therapy programs. The company ended the quarter with $377.7 million in cash, which it expects will fund operations into mid-2028. Key catalysts ahead include an FDA meeting on the SGT-003 accelerated approval pathway in late Q4 2026 and initial Phase 1b data for SGT-212 in Q1 2027. The higher burn rate reflects advancing clinical trials, but the strong cash position provides a multi-year runway.

At the time of this announcement, SLDB was trading at $8.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $857.5M. The 52-week trading range was $3.79 to $11.45. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

SLDB - Latest Insights

SLDB
Nov 04, 2026, 4:07 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $6.52
Real-time Price: $6.60 info
Change: +$0.080 (+1%) info
Market Cap: $699.109M info
SLDB
Nov 04, 2026, 4:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.52
Real-time Price: $6.60 info
Change: +$0.080 (+1%) info
Market Cap: $699.109M info
SLDB
Aug 14, 2026, 5:22 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $9.38
Real-time Price: $6.60 info
Change: -$2.78 (-30%) info
Market Cap: $699.109M info
SLDB
Aug 06, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.25
Real-time Price: $6.60 info
Change: -$1.65 (-20%) info
Market Cap: $699.109M info
SLDB
Jun 24, 2026, 6:49 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $9.29
Real-time Price: $6.60 info
Change: -$2.69 (-29%) info
Market Cap: $699.109M info